A Meta-Analysis of Randomized Controlled Trials Appraising the Efficacy and Safety of Cilostazol after Coronary Artery Stent Implantation-Reference-Cited by-同舟云学术

A Meta-Analysis of Randomized Controlled Trials Appraising the Efficacy and Safety of Cilostazol after Coronary Artery Stent Implantation

Published:2012 Issue:3 Volume:122 Page:133-143
ISSN:1421-9751
Container-title:Cardiology
language:en
Short-container-title:Cardiology

Author:

Jang Jae-Sik,Jin Han-Young,Seo Jeong-Sook,Yang Tae-Hyun,Kim Dae-Kyeong,Kim Dong-Soo,Kim Dong-Kie,Seol Sang-Hoon,Kim Doo-Il,Cho Kyoung-Im,Kim Bo-Hyun,Park Yong Hyun,Je Hyung-Gon,Jeong Young-Hoon,Kim Won-Jang,Lee Jong-Young,Lee Seung-Whan

Publisher

S. Karger AG

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention

2. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

3. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents

4. Established and evolving medical therapies for claudication in patients with peripheral arterial disease

5. Coronary Stent Restenosis in Patients Treated With Cilostazol

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review and Meta-Analysis of Efficacy and Safety of Cilostazol Prescription in Patients With Femoropopliteal Peripheral Artery Disease After Endovascular Therapy;Journal of Endovascular Therapy;2024-04-09

2. Cilostazol regulates the expressions of endothelin‑1 and endothelial nitric oxide synthase via activation of the p38 MAPK signaling pathway in HUVECs;Biomedical Reports;2022-07-29

3. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial;International Journal of Stroke;2022-07-21

4. Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin Inhibitors;Journal of Cardiovascular Pharmacology;2022-07

5. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants after Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06